In this study, SHROOM2 expression was found to correlate with various immune checkpoint molecules, particularly PD-L1, across multiple cancer types, suggesting that SHROOM2 may influence immune checkpoint function in cancer. The gene discussed is SHROOM2; the disease is cancer.